#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema Systemic sclerosis pulmonary Pulmonary alveolar haemorrhage Stevens-Johnson syndrome Acute myeloid leukaemia (in remission) Short-bowel syndrome Vascular calcification Cholangitis sclerosing Ataxia telangiectasia Adrenoleukodystrophy Glomerulonephritis rapidly progressive Mitochondrial encephalomyopathy Myelodysplastic syndrome with excess blasts Progressive supranuclear palsy Haemophilia More trials…

    Learn about Rare Diseases

    Propionic acidaemia – Treatment Piriformis syndrome Myelodysplastic syndrome with excess blasts – Basic Information Osteosarcoma – Trials in Disease Aicardi-Goutieres syndrome – Treatment Andersen-Tawil syndrome – Life with Disease Glycogen storage disease type II Pleomorphic leiomyosarcoma – Trials in Disease Breast angiosarcoma – Diagnostics Glomerulonephritis rapidly progressive – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lutetium (177Lu) Oxodotreotide Posaconazole Osilodrostat Infliximab Bgb-A445 ZINC GLUCONATE Tipiracil Hydrochloride Caplacizumab VALACICLOVIR HYDROCHLORIDE Daxdilimab AUR200 Sapropterin Dihydrochloride Belatacept Isatuximab Alpha-Tocopherol Tenofovir Alafenamide ARLOCABTAGENE AUTOLEUCEL Cefuroxime Sulfamethoxazole Fentanyl More therapies…

    Learn about Your Condition

    Complex regional pain syndrome Pulmonary embolism Torticollis Stress cardiomyopathy Hyperthyroidism Post cardiac arrest syndrome Hairy cell leukaemia Dermatitis atopic Exposure via breast milk Ataxia telangiectasia Cervix carcinoma Breast cancer female Peritoneal sarcoma Neuralgia Mitral valve prolapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis perforated
    • Complicated appendicitis
    • Peritoneal abscess
    Investigated Drugs:
    • Gentamicin
    • Clindamycin
    The Netherlands

  • Study on Optimizing Ravulizumab Dosing for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Ravulizumab
    The Netherlands

  • Study to Optimize Cytokine Release Syndrome for Glofitamab with Gemcitabine and Oxaliplatin in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

    Recruiting

    2 1 1 1
    France Germany Italy

  • Study on the Effectiveness of Dermatophagoides Allergen Extracts and Histamine Dihydrochloride for Patients with Allergies

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Dermatophagoides Farinae
    • Dermatophagoides Pteronyssinus
    • Histamine Dihydrochloride
    Spain

  • Study on the Effectiveness of Autovaccines Compared to Antibiotics for Patients with Hip or Knee Prosthesis Infections

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • Clindamycin Hydrochloride
    • Clotrimazole
    Spain

  • Study on the Safety and Effects of NTRX-07 for Patients with Mild Cognitive Impairment or Mild to Moderate Alzheimer’s Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • (3-BENZYL-3-METHYL-2,3-DIHYDROBENZOFURAN-6- YL)(PIPERIDIN-1-YL)METHANONE
    Czechia Hungary Poland
Previous Page
1 … 272 273 274 275 276 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!